Live Breaking News & Updates on Taps Croskery As Director Of Subsidiary

News Category Global Banking & Finance Reviews
Ehave, Inc. Closes 20/20 Global Transaction, Mycotopia Therapy Now Operating as a Publicly Traded Company with Intent to Focus on Psychedelic Sector
Ehave, Inc. Closes 20/20 Global Transaction, Mycotopia Therapy Now Operating as a Publicly Traded Company with Intent to Focus on Psychedelic Sector
MIAMI, Jan. 20, 2021 Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader in digital therapeutics, announced today the Company has closed the transaction to sell 100% of its
Mycotopia Therapy subsidiary to 20/20 Global Inc. (OTC Pink: TWGL). As a result of the transaction closing, Ehave controls approximately 75.77% of the outstanding shares of 20/20 Global. 20/20 Global Inc. plans to file with FINRA to change the name of the company to Mycotopia Therapy. ....

United States , Mark Croskery , Gabe Rodriguez , Ben Kaplan , Global Inc , Electronic Health Records Ehrs , Risk Factors In Ehave Inc , Croskery Capital , Contact For Ehave Inc , Exchange Commission , Ehave Magic Mushroom Company To Enter Jamaica , Additional Ehave Inc , Ehave Inc , Croskery Capital Limited , Jamaica Gleaner , Magic Mushroom Company To Enter Jamaica , Taps Croskery As Director Of Subsidiary , Kaya As Wellness Adviser And , Mycotopia Therapies , Ehave Dashboard , Electronic Health Records , Ehave Telemetry Portal , Ehave Infinity Portal , Mycotopia Therapy , Private Securities Litigation Reform Act , Registration Statement ,